Americas

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

Latest Americas Analysis

Industry Trend Analysis - Regional Diabetes Treatment Demand To Be Driven By Two Markets - JULY 2017

The Latin America region represents a significant opportunity for diabetes-related medicines given poor diet, low levels of physical activity and a high prevalence of obesity. Levels of diagnosis and access to medicines are poor; therefore, drugmakers will need to cooperate in access schemes and disease prevention programmes to exploit the region's underlying demand. We highlight Mexico as the...

READ FULL ARTICLE...

Industry Trend Analysis - Significant Opportunities For Cardiovascular Diseases - JUNE 2017

Innovative medicines treating cardiovascular diseases will generate most of their revenue in developed markets. However, there is also significant demand for cheaper generic alternatives to cardiovascular therapeutics in emerging markets. Latin America represents a considerable growth opportunity given the high levels of obesity and raised blood cholesterol among the region's large and expandin...

READ FULL ARTICLE...

Industry Trend Analysis - Limited Drugmaker Opportunities Underpinned By Small Pharmaceutical Market - MAY 2017

Growth within Trinidad & Tobago's pharmaceutical market will be supported by the government's push towards advancing healthcare availability and accessibility. However, local drug manufacturing is severely limited which, coupled with a weak business climate, makes for a challenging environment for pharmaceutical firms to operate in. Plans to prioritise spending on healthcare will have...

READ FULL ARTICLE...